statistiche ricercatore

Continente	#
NA - Nord America	697
AS - Asia	332
EU - Europa	213
SA - Sud America	49
Continente sconosciuto - Info sul continente non disponibili	13
AF - Africa	9
OC - Oceania	1
Totale	1.314

Nazione	#
US - Stati Uniti d'America	680
SG - Singapore	123
CN - Cina	97
BR - Brasile	44
HK - Hong Kong	37
IT - Italia	37
DE - Germania	35
UA - Ucraina	35
FI - Finlandia	24
VN - Vietnam	24
GB - Regno Unito	22
RU - Federazione Russa	14
CA - Canada	12
TR - Turchia	12
FR - Francia	11
IE - Irlanda	8
IN - India	7
AT - Austria	6
BD - Bangladesh	6
ID - Indonesia	6
ES - Italia	5
IQ - Iraq	5
JP - Giappone	5
SE - Svezia	4
ZA - Sudafrica	4
BE - Belgio	3
PK - Pakistan	3
NL - Olanda	2
OM - Oman	2
SK - Slovacchia (Repubblica Slovacca)	2
TT - Trinidad e Tobago	2
UY - Uruguay	2
AL - Albania	1
AU - Australia	1
CL - Cile	1
CO - Colombia	1
CZ - Repubblica Ceca	1
DZ - Algeria	1
EC - Ecuador	1
ET - Etiopia	1
GD - Grenada	1
KE - Kenya	1
KG - Kirghizistan	1
LA - Repubblica Popolare Democratica del Laos	1
LV - Lettonia	1
MU - Mauritius	1
MX - Messico	1
MY - Malesia	1
NI - Nicaragua	1
PL - Polonia	1
PT - Portogallo	1
SA - Arabia Saudita	1
TN - Tunisia	1
UZ - Uzbekistan	1
Totale	1.301

Nome	#
Role of 18F-FDG PET/CT in restaging and follow-up of patients with uterine sarcomas	181
Clinical and prognostic value of 18 F-FDG PET/CT in recurrent endometrial carcinoma	164
Claudin 7 downregulation is predictive of distant metastasis in high-grade serous carcinoma patients	147
Low Expression of Claudin-7 as Potential Predictor of Distant Metastases in High-Grade Serous Ovarian Carcinoma Patients	145
Pre-treatment Serum HE4 Level as a Novel Independent Prognostic Biomarker for Uterine Cervical Carcinoma Patients	120
Herpes gestationis associated with normal pregnancy or complete hydatiform mole: report of three cases	119
Patterns of Recurrence and Clinical Outcome of Patients with Stage IIIC to Stage IV Epithelial Ovarian Cancer in Complete Response after Primary Debulking Surgery Plus Chemotherapy or Neoadjuvant Chemotherapy Followed by Interval Debulking Surgery: An Italian Multicenter Retrospective Study	113
Mutational landscape of primary, metastatic, and recurrent ovarian cancer reveals c-MYC gains as potential target for BET inhibitors	96
Correction for Li et al., Mutational landscape of primary, metastatic, and recurrent ovarian cancer reveals c-MYC gains as potential target for BET inhibitors	90
Laparoscopic management of a large urethral leiomyoma	75
Fertility Sparing Team	64
Totale	1.314

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	50	0	6	2	3	1	4	0	6	4	5	6	13
2022/2023	91	10	4	3	4	7	19	0	18	16	1	7	2
2023/2024	93	5	3	15	8	3	23	2	4	17	4	1	8
2024/2025	221	1	3	2	23	14	29	16	11	27	18	47	30
2025/2026	501	50	57	30	85	71	38	86	14	13	36	15	6
2026/2027	29	13	16	0	0	0	0	0	0	0	0	0	0
Totale													1.314